{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:24:46Z","timestamp":1761513886073,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"European Commission FP7","award":["305485 PREVENT-ROP"],"award-info":[{"award-number":["305485 PREVENT-ROP"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["EY024864","EY017017","P01 HD18655"],"award-info":[{"award-number":["EY024864","EY017017","P01 HD18655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ghir.2016.09.005","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T05:18:10Z","timestamp":1475212690000},"page":"75-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["IGF-I in the clinics: Use in retinopathy of prematurity"],"prefix":"10.1016","volume":"30-31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-1244","authenticated-orcid":false,"given":"Ann","family":"Hellstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Hansen-Pupp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boubou","family":"Hallberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca A.","family":"Ramenghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatarina","family":"L\u00f6fqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois E.H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Lena","family":"H\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2016.09.005_bb0005","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2016.09.005_bb0010","doi-asserted-by":"crossref","first-page":"F99","DOI":"10.1136\/archdischild-2015-308221","article-title":"Preventing bioenergetic failure in the preterm infant","volume":"101","author":"Martin","year":"2016","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.ghir.2016.09.005_bb0015","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1651-2227.2009.01568.x","article-title":"New insights into the development of retinopathy of prematurity-importance of early weight gain","volume":"99","author":"Hellstrom","year":"2010","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2016.09.005_bb0020","doi-asserted-by":"crossref","first-page":"E991","DOI":"10.1152\/ajpendo.90452.2008","article-title":"Abnormalities of IGF-I signaling in the pathogenesis of diseases of the bone, brain, and fetoplacental unit in humans","volume":"295","author":"Laviola","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.005_bb0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2009-0010","article-title":"The role of liver-derived insulin-like growth factor-I","volume":"30","author":"Ohlsson","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2016.09.005_bb0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0306-4522(97)00367-9","article-title":"Insulin-like growth factor-I modulation of cerebellar cell populations is developmentally stage-dependent and mediated by specific intracellular pathways","volume":"83","author":"Torres-Aleman","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.ghir.2016.09.005_bb0035","first-page":"801","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2016.09.005_bb0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2016.09.005_bb0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mob.2003.26","article-title":"Regulation of insulin-like growth factor-I and insulin-like growth factor binding protein-1 concentrations in preterm fetuses","volume":"188","author":"Verhaeghe","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1203\/00006450-199103000-00001","article-title":"Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation","volume":"29","author":"Lassarre","year":"1991","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2016.09.005_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/cen.13057","article-title":"Neonatal adiposity increases with rising cord blood IGF-I levels","volume":"85","author":"Kadakia","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0060","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jcem-66-2-422","article-title":"Expression of somatomedin\/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution","volume":"66","author":"Han","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.005_bb0065","first-page":"5","article-title":"Growth hormone, insulin-like growth factor-I and somatostatin in human fetus, newborn, mother plasma and amniotic fluid","volume":"36","author":"Bona","year":"1994","journal-title":"Panminerva Med."},{"key":"10.1016\/j.ghir.2016.09.005_bb0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1469-7580.2008.01035.x","article-title":"Insulin and the IGF system in the human placenta of normal and diabetic pregnancies","volume":"215","author":"Hiden","year":"2009","journal-title":"J. Anat."},{"key":"10.1016\/j.ghir.2016.09.005_bb0075","first-page":"499","article-title":"Insulin-like growth factor-I is a marker for the nutritional state","volume":"13","author":"Hawkes","year":"2015","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ghir.2016.09.005_bb0080","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1523\/JNEUROSCI.11-11-03442.1991","article-title":"Transient IGF-I gene expression during the maturation of functionally related central projection neurons","volume":"11","author":"Bondy","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ghir.2016.09.005_bb0085","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1523\/JNEUROSCI.12-12-04737.1992","article-title":"Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development","volume":"12","author":"Lee","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ghir.2016.09.005_bb0090","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1167\/iovs.08-2903","article-title":"Quantification and localization of the IGF\/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice","volume":"50","author":"Lofqvist","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ghir.2016.09.005_bb0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1203\/00006450-199410000-00020","article-title":"Ontogeny of insulin-like growth factor-binding protein-1, -2, and -3: quantitative measurements by radioimmunoassay in human fetal serum","volume":"36","author":"Bang","year":"1994","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2016.09.005_bb0100","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1651-2227.2007.00276.x","article-title":"Inflammation at birth and the insulin-like growth factor system in very preterm infants","volume":"96","author":"Hansen-Pupp","year":"2007","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2016.09.005_bb0105","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2010-2440","article-title":"Postnatal decrease in circulating insulin-like growth factor-I and low brain volumes in very preterm infants","volume":"96","author":"Hansen-Pupp","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.005_bb0110","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/apa.13350","article-title":"Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development","volume":"105","author":"Hellstr\u00f6m","year":"2016","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2016.09.005_bb0115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","article-title":"Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth","volume":"112","author":"Hellstrom","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2016.09.005_bb0120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0021-5155(01)00499-3","article-title":"Modulation of insulin-like growth factor-I production of cultured vascular endothelial cells by oxygen,gucose and growth hormone","volume":"46","author":"Eter","year":"2002","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1471-4159.2001.00325.x","article-title":"Effects of insulin-like growth factor-1 on retinal endothelial cell grucose transport and proliferation","volume":"77","author":"DeBosch","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ghir.2016.09.005_bb0130","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1471-4159.2002.00848.x","article-title":"Insulin-like growth factor-1 effects on bovine retinal endothelial cell glucose transport: role of MAP kinase","volume":"81","author":"DeBosch","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ghir.2016.09.005_bb0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/meta.2003.50046","article-title":"High glucose concentration decreases insulin-like growth factor type 1\u2013mediated mitogen-activated protein kinase activation in bovine retinal endothelial cells","volume":"52","author":"McBain","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2016.09.005_bb0140","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-14-0215","article-title":"Endothelial cells and the IGF system","volume":"54","author":"Bach","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0145","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","article-title":"Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity","volume":"98","author":"Hellstrom","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ghir.2016.09.005_bb0150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1164\/rccm.200506-927OC","article-title":"Growth of pulmonary microvasculature in ventilated preterm infants","volume":"173","author":"De Paepe","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ghir.2016.09.005_bb0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0035-1563533","article-title":"Brain perfusion is increased at term in the white matter of very preterm newborns and newborns with congenital heart disease: does this reflect activated angiogenesis?","volume":"46","author":"Wintermark","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ghir.2016.09.005_bb0160","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ghir.2016.09.005_bb0165","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0170","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.preteyeres.2009.06.003","article-title":"The neurovascular retina in retinopathy of prematurity","volume":"28","author":"Fulton","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ghir.2016.09.005_bb0175","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2016.09.005_bb0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0185","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0140-6736(73)92610-X","article-title":"Cost of preventing retrolental fibroplasia?","volume":"2","author":"Cross","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2016.09.005_bb0190","first-page":"352","article-title":"Oxygen saturation targets for extremely preterm infants after the NeOProM trials","volume":"109","author":"Stenson","year":"2016","journal-title":"Neoplasma"},{"key":"10.1016\/j.ghir.2016.09.005_bb0195","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamapediatrics.2014.3307","article-title":"Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis","volume":"169","author":"Manja","year":"2015","journal-title":"JAMA Pediatr."},{"year":"2016","series-title":"Interventions to Prevent Retinopathy of Prematurity: A Meta-Analysis, Pediatrics 137 (2016) E-Pub","author":"Fang","key":"10.1016\/j.ghir.2016.09.005_bb0200"},{"key":"10.1016\/j.ghir.2016.09.005_bb0205","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1203\/PDR.0b013e3182115000","article-title":"Influence of insulin-like growth factor I and nutrition during phases of postnatal growth in very preterm infants","volume":"69","author":"Hansen-Pupp","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2016.09.005_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/B:REMD.0000032408.18015.b1","article-title":"Insulin like growth factor-1 and insulin-like growth factor binding proteins: their possible roles in both maintaining normal retinal vascular function and in promoting retinal pathology","volume":"5","author":"Shaw","year":"2004","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ghir.2016.09.005_bb0215","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/70963","article-title":"Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor","volume":"5","author":"Smith","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.ghir.2016.09.005_bb0220","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI200317455","article-title":"Knockout of insulin and IGF-I receptors on vascular endothelial cells protects against retinal neovascularization","volume":"111","author":"Kondo","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2016.09.005_bb0225","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1001\/archophthalmol.2012.2357","article-title":"Swedish national register for retinopathy of prematurity (SWEDROP) and the evaluation of screening in Sweden","volume":"130","author":"Holmstrom","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0230","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","article-title":"Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity","volume":"124","author":"Lofqvist","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0235","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archophthalmol.2009.69","article-title":"Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I","volume":"127","author":"Lofqvist","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0240","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1542\/peds.2008-2697","article-title":"Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening","volume":"123","author":"Hellstrom","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2016.09.005_bb0245","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archophthalmol.2012.243","article-title":"Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity","volume":"130","author":"Wu","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0250","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archophthalmol.2012.215","article-title":"Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants","volume":"130","author":"Zepeda-Romero","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ghir.2016.09.005_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diab.2.1.7","article-title":"Recovery from retinopathy in a case of diabetes with Simmonds' disease","volume":"2","author":"Poulsen","year":"1953","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2016.09.005_bb0260","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1126\/science.276.5319.1706","article-title":"Essential role of growth hormone in ischemia-induced retinal neovascularization","volume":"276","author":"Smith","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ghir.2016.09.005_bb0265","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ghir.2016.09.005_bb0270","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1203\/PDR.0b013e3181973dc8","article-title":"Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration","volume":"65","author":"Vanhaesebrouck","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2016.09.005_bb0275","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jc.2008-1293","article-title":"Fresh-frozen plasma as a source of exogenous insulin-like growth factor-I in the extremely preterm infant","volume":"94","author":"Hansen-Pupp","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.005_bb0280","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1023\/A:1010991313633","article-title":"Kinetic analysis of the disposition of insulin-like growth factor 1 in healthy volunteers","volume":"18","author":"Mizuno","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ghir.2016.09.005_bb0285","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1203\/PDR.0b013e31819d9e8c","article-title":"A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants","volume":"65","author":"Lofqvist","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2016.09.005_bb0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/pr.2012.146","article-title":"Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety","volume":"73","author":"Ley","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2016.09.005_bb0295","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpeds.2015.10.005","article-title":"Higher rates of retinopathy of prematurity after increasing oxygen saturation targets for very preterm infants: experience in a single center","volume":"168","author":"Manley","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2016.09.005_bb0300","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.7812\/TPP\/11.998","article-title":"Maintaining optimal oxygen saturation in premature infants","volume":"15","author":"Lau","year":"2011","journal-title":"Perm. J."},{"key":"10.1016\/j.ghir.2016.09.005_bb0305","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1440-1754.2009.01680.x","article-title":"Improving compliance with pulse oximetry alarm limits for very preterm infants?","volume":"46","author":"Mills","year":"2010","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.ghir.2016.09.005_bb0310","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00431-015-2643-0","article-title":"Compliance in oxygen saturation targeting in preterm infants: a systematic review","volume":"174","author":"van Zanten","year":"2015","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ghir.2016.09.005_bb0315","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1542\/peds.2005-0413","article-title":"Achieved versus intended pulse oximeter saturation in infants born <28weeks' gestation: the AVIOx study","volume":"118","author":"Hagadorn","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2016.09.005_bb0320","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jpeds.2015.06.012","article-title":"Automated versus manual oxygen control with different saturation targets and modes of respiratory support in preterm infants","volume":"167","author":"van Kaam","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2016.09.005_bb0325","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1542\/peds.111.2.339","article-title":"Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?","volume":"111","author":"Chow","year":"2003","journal-title":"Pediatrics"}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637416300557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637416300557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:50:16Z","timestamp":1761087016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637416300557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":65,"alternative-id":["S1096637416300557"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2016.09.005","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF-I in the clinics: Use in retinopathy of prematurity","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2016.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}